Apple’s new record
Apple to buy back US$110B worth of shares while former ASX-200 company set to delist this month. Get your 3-minute weekly dose of financial news.
Google’s surprise announcement
Google to pay out a dividend for the first time in history. Microsoft gains while Meta falls following earnings. Get your 3-minute weekly dose of financial news.
No more sharing for Netflix
Netflix cracked down on password-sharing last year… next year, it’ll stop sharing subscriber numbers. Get your 3-minute weekly dose of financial news.
Fashion meets AI
Rent the Runway soars after name dropping AI, while Qantas releases new rewards seats. Get your 3-minute weekly dose of financial news.
Disney’s fireworks finale
Disney finally ends its long-drawn battle with a happy ending. Get your 3-minute weekly dose of financial news.
Trump ‘loves the Truth’
Donald Trump's social media platform has debuted on the U.S. Markets through a SPAC. Get your 3-minute weekly dose of financial news.
Wall Street’s bet on Reddit
Reddit jumps almost 50% on its first day while Apple is down 7.7% for the year. Get your 3-minute weekly dose of financial news.
The EV challenging Tesla and Porsche
A certain smartphone brand believes its EV to be a Tesla and Porsche rival while Liontown is now back on track. Get your 3-minute weekly dose of financial news.
Meta cancels its news feed
Meta will no longer invest in Facebook News and won't renew $66m worth of deals with Australia’s media industry.
C3.ai joins the AI bonanza
C3.ai shares jump 40% and Coles outshines Woolworths with stronger earnings results. Get your 3-minute weekly dose of financial news.
NVIDIA surpasses Amazon, Alphabet, Tesla and Meta
Hey Superheroes, The ASX was filled with excitement this week as big Aussie names including BHP, Fortescue Metals and Woolworths released half-year earnings reports. On Wall Street, NVIDIA swept up all headlines this week with its blockbuster quarterly earnings report. Let’s get into it. NVIDIA gains US$250b market cap overnight NVIDIA’s share price jumped about […]
CSL’s heart medicine misses a beat
CSL’s “blockbuster” drug trial set to go on for much longer than expected. Get your 3-minute weekly dose of financial news.